SCHEMBL27056167

SCHEMBL27056167

CN1CCCCC1CN1c2ccccc2SC2C=CC=CC21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA2A P08913 3/20 0.43
▸ PIM1 P11309 5/20 0.41
▸ HTR6 P50406 5/20 0.40
▸ HTR1A P08908 4/20 0.40
▸ DRD1 P21728 4/20 0.40
▸ DRD3 P35462 4/20 0.40
▸ CYP1A2 P05177 3/20 0.40
▸ CYP2D6 P10635 3/20 0.40
▸ TDP1 Q9NUW8 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ DRD2 P14416 3/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ TP53 P04637 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ ALOX15 P16050 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ CHRM2 P08172 2/20 0.40
▸ SLC6A2 P23975 2/20 0.40
▸ ADRA1A P35348 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27056141 0.76 KDM1A (0.39) ADRA2AHTR1ADRD1DRD3CHRM2
SCHEMBL14434182 0.76 CHRM2 (0.54) ADRA2AHTR1ADRD1DRD3CYP1A2
SCHEMBL14433981 0.76 CHRM2 (0.54) ADRA2AHTR1ADRD1DRD3CYP1A2
SCHEMBL14434185 0.76 CHRM2 (0.54) ADRA2AHTR1ADRD1DRD3CYP1A2
SCHEMBL27056189 0.75 CYP2D6 (0.40) ADRA2AHTR6HTR1ADRD1DRD3
SCHEMBL19759877 0.75 ALDH1A1 (0.33) MAOAALDH1A1SMN1; SMN2NPSR1
SCHEMBL27056147 0.74 KCNH2 (0.41) ADRA2AHTR6DRD1DRD3CYP1A2
SCHEMBL14682732 0.74 DRD2 (0.56) ADRA2APIM1HTR6HTR1ADRD1
SCHEMBL15362395 0.73 PIM1 (0.48) ADRA2APIM1HTR6HTR1ADRD1
SCHEMBL29799376 0.71 PIM1 (0.63) ADRA2APIM1HTR6HTR1ADRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3473254-B1 PHENOTHIAZINE DERIVATIVES FOR THE TREATMENT OF AUTOIMMUNE DISEASES HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH (DE) 2024-01-24 — — EP disclosed
Send feedback